XML 17 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Apr. 28, 2012
Apr. 30, 2011
OPERATING ACTIVITIES:    
Net income $ 26,096 $ 3,142
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 47,047 46,894
Bad debt expense, net 180 12
Gain on sale of fixed assets (12,578) (6,810)
Write-off of deferred financing costs 0 2,337
Deferred 4,330 4,494
Stock-based compensation 4,901 3,086
Amortization of debt issuance costs 971 975
Excess tax benefit from share-based awards (1,361) (251)
Change in operating assets and liabilities:    
Accounts receivable, net 16,734 14,590
Costs and estimated earnings in excess of billings, net (14,789) (6,073)
Other current assets and inventory (12,427) (3,361)
Other assets (146) 807
Income taxes receivable 9,383 (3,210)
Accounts payable 1,903 (1,144)
Accrued liabilities, insurance claims, and other liabilities (1,791) (3,398)
Net cash provided by operating activities 68,453 52,090
INVESTING ACTIVITIES:    
Capital expenditures (62,790) (32,255)
Proceeds from sale of assets 20,528 9,690
Cash paid for acquisitions 0 (36,500)
Changes in restricted cash 550 216
Net cash used in investing activities (41,712) (58,849)
FINANCING ACTIVITIES:    
Proceeds from issuance of 7.125% senior subordinated notes due 2021 0 187,500
Principal payments on long-term debt (186) (135,667)
Debt issuance costs 0 (5,105)
Repurchases of common stock (10,942) (55,491)
Exercise of stock options and other 5,299 1,174
Restricted stock tax withholdings (329) (196)
Excess tax benefit from share-based awards 1,361 251
Net cash provided by (used in) financing activities (4,797) (7,534)
Net increase (decrease) in cash and equivalents 21,944 (14,293)
CASH AND EQUIVALENTS AT BEGINNING OF PERIOD 44,766 103,320
CASH AND EQUIVALENTS AT END OF PERIOD 66,710 89,027
Cash paid during the period for:    
Interest 8,220 10,327
Income taxes 2,697 2,786
Purchases of capital assets included in accounts payable or other accrued liabilities at period end $ 1,683 $ 2,138